The Patent Finder

Heteroaryl Substituted Pyrrolo[2,3-b] Pyridines And Pyrrolo[2,3-b] Pyrimidines As Janus Kinase Inhibitors

Incyte Corporation

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 7 of these applications claim priority to application 14/711,576, filed May 13, 2015. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 8,530,485Heteroaryl Substituted Pyrrolo[2,3-b]pyridines and Pyrrolo[2,3-b]pyrimidines as Janus Kinase Inhibitors
In force
 · High confidence
UsedRemaining
Incyte Holdings Corporation and Incyte CorporationIn forceHigh confidence
US 8,933,086Heteroaryl Substituted Pyrrolo[2,3-b]pyridines And Pyrrolo[2,3-b]pyrimidines As Janus Kinase Inhibitors
In force
 · High confidence
Incyte Holdings Corporation and Incyte CorporationIn forceHigh confidence
US 8,946,245HETEROARYL SUBSTITUTED PYRROLO[2,3-b]PYRIDINES AND PYRROLO[2,3-b]PYRIMIDINES AS JANUS KINASE INHIBITORS
In force
 · High confidence
Incyte Holdings Corporation and Incyte CorporationIn forceHigh confidence
US 9,079,912Heteroaryl Substituted Pyrrolo[2,3-b] Pyridines And Pyrrolo[2,3-b] Pyrimidines As Janus Kinase Inhibitors
In force
 · High confidence
Incyte Holdings Corporation and Incyte CorporationIn forceHigh confidence
US 9,206,187Heteroaryl Substituted Pyrrolo[2,3-b] Pyridines And Pyrrolo[2,3-b] Pyrimidines As Janus Kinase Inhibitors
In force
 · High confidence
Incyte Holdings Corporation and Incyte CorporationIn forceHigh confidence
US 9,662,335Heteroaryl Substituted Pyrrolo[2,3-b] Pyridines And Pyrrolo[2,3-b] Pyrimidines As Janus Kinase Inhibitors
In force
 · High confidence
Incyte Holdings CorporationIn forceHigh confidence
US 9,814,722Heteroaryl Substituted Pyrrolo[2,3-b] Pyridines And Pyrrolo[2,3-b] Pyrimidines As Janus Kinase Inhibitors
In force
 · High confidence
Incyte Holdings CorporationIn forceHigh confidence
US 9,974,790Heteroaryl Substituted Pyrrolo[2,3-b] Pyridines And Pyrrolo[2,3-b] Pyrimidines As Janus Kinase Inhibitors
In force
 · High confidence
Incyte Holdings CorporationIn forceHigh confidence
US 10,398,699HETEROARYL SUBSTITUTED PYRROLO[2,3-b]PYRIDINES AND PYRROLO[2,3-b]PYRIMIDINES AS JANUS KINASE INHIBITORS
In force
 · High confidence
Incyte Holdings CorporationIn forceHigh confidence
US 10,639,310Heteroaryl Substituted Pyrrolo[2,3-b]pyridines and Pyrrolo[2,3-b]pyrimidines as Janus Kinase Inhibitors
In force
 · High confidence
Incyte Holdings CorporationIn forceHigh confidence
7 more records in this group · Pro
10 of 17 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 17, including 15 expiring within the 18 months from Nov 21, 2026.
Upgrade to Pro
7 of these are in force and held by Incyte Corporation.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited